Invention Grant
- Patent Title: Ergostenol glycoside derivative
-
Application No.: US16518478Application Date: 2019-07-22
-
Publication No.: US11059852B2Publication Date: 2021-07-13
- Inventor: Hakwon Kim , Tae Hoon Lee , Hoongyu Park , Hyunjeong Oh
- Applicant: ST PHARM CO., LTD.
- Applicant Address: KR Siheung-si
- Assignee: ST PHARM CO., LTD.
- Current Assignee: ST PHARM CO., LTD.
- Current Assignee Address: KR Siheung-si
- Agency: Lucas & Mercanti, LLP
- Priority: KR10-2017-0010639 20170123
- Main IPC: C07J17/00
- IPC: C07J17/00 ; C07H15/24 ; A61P17/00 ; A61K31/7034 ; A61K8/63

Abstract:
The present invention provides ergostenol glycoside derivatives, method for preventing, treating, or alleviating dermatitis using the same. The present invention also provides a method for preparing the ergostenol and glycoside derivatives thereof. The ergostenol and the glycoside derivatives thereof according to the present invention suppress the production of chemokines increasing according to the skin inflammation stimulation and inhibit the activity of transcriptional factors controlling the expression of various inflammation mediators in the prevention and treatment of dermatitis.
Public/Granted literature
- US20190337976A1 NOVEL ERGOSTENOL GLYCOSIDE DERIVATIVE Public/Granted day:2019-11-07
Information query